• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BARD PERIPHERAL VASCULAR, INC. CARBOFLO VASCULAR GRAFT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BARD PERIPHERAL VASCULAR, INC. CARBOFLO VASCULAR GRAFT Back to Search Results
Catalog Number F70T74TSC
Device Problem Torn Material (3024)
Patient Problems No Patient Involvement (2645); No Known Impact Or Consequence To Patient (2692)
Event Date 01/30/2013
Event Type  malfunction  
Manufacturer Narrative
A further clinical review of the event details was completed and a change in the mdr reportability was identified.No medical records or no medical images have been made available to the manufacturer.As the lot number for the device was provided, a review of the device history records is currently being performed.The device has been returned to the manufacturer for evaluation.The investigation of the reported event is currently underway.The information provided by bard represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bard.
 
Event Description
It was reported that during the preparation of a vascular graft, it was discovered that the graft was torn.Another vascular graft was prepared and successfully implanted.There is no reported patient injury.
 
Manufacturer Narrative
Manufacturing review: a manufacturing review was conducted and there was nothing found to indicate there was a manufacturing related cause for this event.Visual inspection: segment 1: the graft was returned used.Approximately 5 rows of beading were removed on one end of the graft.An unknown tie, possibly a suture, was attached to the opposite end of the graft.One partial circumferential tear was observed along the beading track where the beading had been removed.The tear was located approximately 1cm from the edge of the graft there were no signs of stretching at the locations of the tears.The removed beading was still attached to the graft.Segment 2: there was no beading removed from the graft.No tears were identified along the graft.One end of the graft appeared to be slightly compressed.It is unknown how or when the graft was compressed as it was not reported by the user.Segment 3: approximately ½ a row of beading was still present on the graft.Two partial circumferential tears were identified along the first and second beading track.Uneven trimming was identified on one end of the graft.Functional/performance evaluation: an attempt was made to remove the remaining beading at the trimmed end of segment 2.The beading was removed by hand, slowly and at a 90 degree angle to the graft, per the ifu.Approximately 10 rows of beading were removed using this method.There were no holes, rips, or tears noted along the beading track of the newly removed beading.10 more rows of beading were removed.This time, the beading was removed by quickly pulling the beading longitudinally.When removed in this manner, there were still no signs of holes, rips, or tears along the beading track.However, the indentation of the beading track was more pronounced and looked partly gouged in some areas.Medical records review: medical records were not provided; therefore, a review could not be performed.Image/photo review: images/photos were not provided; therefore, a review could not be performed.Conclusion: the investigation is confirmed for torn material, as a partial circumferential tears was observed along the beading track of segment 1 and segment 3.Labeling review: the current instructions for use (ifu)provides general instructions for use of the device, as well as warnings, precautions, and potential complications associated with the device.The information provided by bard represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bard.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CARBOFLO VASCULAR GRAFT
Type of Device
VASCULAR GRAFT
Manufacturer (Section D)
BARD PERIPHERAL VASCULAR, INC.
1625 west 3rd st.
tempe AZ 85281
Manufacturer (Section G)
BARD PERIPHERAL VASCULAR, INC.
1625 west 3rd st.
tempe AZ 85281
Manufacturer Contact
judith ludwig
1625 west 3rd st.
tempe, AZ 85281
4803032689
MDR Report Key5355217
MDR Text Key35821190
Report Number2020394-2016-00027
Device Sequence Number1
Product Code DYF
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K004012
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 01/30/2013
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/08/2016
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date09/30/2017
Device Catalogue NumberF70T74TSC
Device Lot Number20693494
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer02/27/2013
Is the Reporter a Health Professional? No
Date Manufacturer Received03/17/2016
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured10/04/2012
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-